346 related articles for article (PubMed ID: 21255547)
1. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
[TBL] [Abstract][Full Text] [Related]
2. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
3. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
Mutneja A; Cossey LN; Liapis H; Chen YM
BMC Nephrol; 2017 Feb; 18(1):57. PubMed ID: 28183278
[TBL] [Abstract][Full Text] [Related]
4. Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.
Flahault A; Vignon M; Rabant M; Hummel A; Noël LH; Canioni D; Knebelmann B; Suarez F; El Karoui K
Medicine (Baltimore); 2016 Oct; 95(41):e5047. PubMed ID: 27741115
[TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman's disease in a Ghanaian adult.
Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A
Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747
[TBL] [Abstract][Full Text] [Related]
6. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
7. A case of multicentric Castleman's disease having lung lesion successfully treated with humanized anti-interleukin-6 receptor antibody, tocilizumab.
Higuchi T; Nakanishi T; Takada K; Matsumoto M; Okada M; Horikoshi H; Suzuki K
J Korean Med Sci; 2010 Sep; 25(9):1364-7. PubMed ID: 20808682
[TBL] [Abstract][Full Text] [Related]
8. Renal failure in pediatric Castleman disease: Four French cases with thrombotic microangiopathy.
Cousin E; Flodrops H; Boyer O; Hogan J; Ruin M; Couderc A; Goujon JM; Taque S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27045. PubMed ID: 29603588
[TBL] [Abstract][Full Text] [Related]
9. Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.
Lederer H; Achermann Y; Tinguely M; Stenner F; Fehr J
Infection; 2012 Apr; 40(2):203-5. PubMed ID: 21837451
[TBL] [Abstract][Full Text] [Related]
10. Overlap of IgG4-related Disease and Multicentric Castleman's Disease in a Patient with Skin Lesions.
Mochizuki H; Kato M; Higuchi T; Koyamada R; Arai S; Okada S; Eto H
Intern Med; 2017; 56(9):1095-1099. PubMed ID: 28458319
[TBL] [Abstract][Full Text] [Related]
11. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
Takeuchi N; Arai T; Kitaichi M; Inoue Y
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
[TBL] [Abstract][Full Text] [Related]
12. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
[TBL] [Abstract][Full Text] [Related]
13. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
[TBL] [Abstract][Full Text] [Related]
14. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
15. Multiple capillary hemangiomas: a distinctive lesion of multicentric Castleman's disease and POEMS syndrome.
Misri R; Kharkar V; Dandale A; Patel V; Mahajan S; Khopkar U
Indian J Dermatol Venereol Leprol; 2008; 74(4):364-6. PubMed ID: 18797059
[TBL] [Abstract][Full Text] [Related]
16. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
Nunes MB; Rotman S; Duss FR; Halfon M
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31911409
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.
Speicher DJ; Sehu MM; Mollee P; Shen L; Johnson NW; Faoagali JL
Am J Transplant; 2014 May; 14(5):1207-13. PubMed ID: 24674650
[TBL] [Abstract][Full Text] [Related]
18. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
[TBL] [Abstract][Full Text] [Related]
19. Clinical dissection of multicentric Castleman disease.
Shin DY; Jeon YK; Hong YS; Kim TM; Lee SH; Kim DW; Kim I; Yoon SS; Heo DS; Park S; Kim BK
Leuk Lymphoma; 2011 Aug; 52(8):1517-22. PubMed ID: 21585280
[TBL] [Abstract][Full Text] [Related]
20. A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
Falchi L; Capello D; Palumbo B; Rauco A; Emili R; Cianciulli M; Pace R; Capparella V; Liberati F; Liberati AM
Eur J Haematol; 2007 Nov; 79(5):455-61. PubMed ID: 17908180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
